baber/WOPTO huggingface dataset:
Patent NZ-247124-A (NZ)
Title: Pyrrolidine carboxamide derivatives and pharmaceutical compositions
Inventor: GORYS VIDA
IPC: A61P31/12
Filed: 1993-03-11
Abstract: Disclosed herein are compounds of formula 1 <CHEM> wherein X is a terminal group, for example, an aryloxycarbonyl or an alkanoyl; B is absent or an amino acid residue, for example, Val or Asn; R<1> is alkyl; and Y is a ring substituent, for example, benzyl, benzyloxy, phenylthio or 2-pyridinylthio. The compounds inhibit the activity of human immunodeficiency virus (HIV) protease and interfere with HIV induced cytopathogenic effects in human cells. These properties render the compounds useful for combating HIV infections.
Patent NZ-269318-A (NZ)
Title: Electro-optic viewer displays image from stored data so that image view coincides with attitude and position of viewer
Inventor: ELLENBY JOHN
IPC: G06T15/10
Filed: 1994-06-16
Abstract: The systems combine images of a real scene with computer generated imagery where the computer generated imagery is particular to the position and pointing attitude of the device. Being useful to spectators of the game baseball, the device can produce images showing where a strike zone is relative to the position of the players; can produce images of ball tracks; of replays and many other forms of information having characteristics dependent on a viewer's position and attitude.
Patent NZ-298494-A (NZ)
Title: Glycosylase mediated detection of nucleotide sequences at candidate loci
Inventor: MCCARTHY THOMAS VALENTINE
IPC: C12Q1/68
Filed: 1995-12-21
Abstract: PCT No. PCT/IE95/00067 Sec. 371 Date Jan. 8, 1998 Sec. 102(e) Date Jan. 8, 1998 PCT Filed Dec. 21, 1995 PCT Pub. No. WO97/03210 PCT Pub. Date Jan. 30, 1997A novel process is presented for the detection of known mutations and polymorphisms in DNA. This process, termed glycosylase mediated polymorphism detection (GMPD) involves amplification of the target DNA using three normal dNTPs and a fourth modified dNTP, whose base is a substrate for a specific DNA-glycosylase once incorporated into the DNA.
Patent NZ-315019-A (NZ)
Title: Mobile station switching from direct mode channel: dual watch or energy economy
Inventor: KINNUNEN KIMMO
IPC: H04B7/26
Filed: 1996-08-13
Abstract: PCT No. PCT/FI96/00437 Sec. 371 Date Apr. 14, 1997 Sec. 102(e) Date Apr. 14, 1997 PCT Filed Aug. 13, 1996 PCT Pub. No. WO97/07604 PCT Pub. Date Feb. 27, 1997A method for synchronizing a telecommunications connection in a mobile communications system including a database, at least one base station communicating with mobile stations on system channels which include control channels and traffic channels. Mobile stations communicate with other mobile stations using the base station and the system channels or communicate directly using a direct mode channel. Time slots and frame structures of the system channels are synchronized with time slots and frame structures of the direct mode channels.
Patent NZ-332989-A (NZ)
Title: Oxidative hair dye composition comprising a 2-hydroxyphenyl benzotriazole compound which absorbs ultraviolet radiation in the wavelength range of 200-400nm
Inventor: HAWKINS GEOFFREY R
IPC: A61K8/00
Filed: 1998-03-17
Abstract: A composition for oxidative dyeing of hair is claimed comprising, by weight of the total composition: a)	0.0001-20% of at least one primary intermediate and at least one coupler for the formation of oxidation dyes; b)	0.01-10% of a 2-hydroxyphenyl benzotriazole compound which absorbs ultraviolet radiation in the wavelength range of 200 to 400 nanometers; c)	0.5-20% surfactant and d)	10-65% water. A two component kit containing the hair dye composition and a developer, and a method for oxidative dyeing of hair with the kit are also claimed.
Patent NZ-333590-A (NZ)
Title: Thiazole compounds, process of manufacture and their use for treating prophylaxis and other diseases
Inventor: ALIG LEO
IPC: C07K5/117
Filed: 1998-12-24
Abstract: Thiazole derivatives of the formula 1 where: R1 is selected from (a), (b), (c) or (d) R2 is formula II R3 is H, alkyl, cycloalkyl, aryl, aralkyl, heteroaryl, carboxy, alkyl-O-CO- or aralkyl-O-CO; R4 is H, alkyl, cyclolakyl, aryl or heteroaryl; R5 and R6 are independently H, alkyl, cycloalkyl or heteroaryl; R7 and R8 are independently H, alkyl, cycloalkyl or aralkyl or R7 and R8 together with the N atoms form a 5 or 6 membered ring which may be optionally substituted with alkyl R9 is H, alkyl or cycloalkyl; R10 is aryl, aralkyl, heterocyclyl, heterocyclyalkyl, hydroxy, H, or alkyl, or R10 is carboxy, carboxyalkyl, alkyl-O-CO-, aralkyl-O-CO-, alkyl-CO-, aralkyl-CO-, heteroarylalkyl-CO-, alkylsulphonyl or heteroarylsulphonyl k is 0, or R10 is an á-amino acid bonded via the amino group and l is 0 and k is 1; A is carbonyl or sulphonyl; B is H, alkyl or cycloalkyl; a-m are 0 or whole positive numbers with a being 0-2 but not being 0 when R1 is -NH2 b being 0-4 c, d, f, g, k, l and m are 0 or 1, where c, f, and g are not 0 at the same time, and when m is not 0 when f, or g is 1 i is 0 or 1, where k and l are also 0 when I is 0; e is 0-3; h is 0-5; j is 0-2 and the sum of e, h and j is 2-7. Further claimed is a process for preparing these compounds, and the use for treating tumours and more.
Patent NZ-333748-A (NZ)
Title: High affinity recombinant interleukin-4 (IL-4) muteins
Inventor: GREVE JEFFREY
IPC: G01N33/534
Filed: 1997-07-09
Abstract: The recombinant interleukin IL-4 muteins have at least one amino acid substitution in the binding surface of either the A- or C- alpha helices.  The amino acid substitutions are in the A -helix are selected from positions 5, 11, 13 and 16, and in the C-helix, positions 77, 78, 81, 84, 85 (except for R85Q) and 89. These muteins bind to the IL-4R alpha receptor with greater affinity than native IL-4 and can be used in the treatment of immune disorders, cancers or tumors, abnormal cell growth or immunomodulation.
Patent NZ-335258-A (NZ)
Title: Differences in 2D electrophoresis protein patterns between hypertensive and healthy animals
Inventor: MULVANY MICHAEL
IPC: C12P21/08
Filed: 1997-10-06
Abstract: Described is a method of detecting, for an individual mammal, a high likelihood or genetic predisposition for having hypertension.  The method comprises determining the presence in a biological sample of at least one marker protein, which is indicative of a high likelihood of having hypertension or a genetic predisposition for having hypertension.  The marker protein used is selected from the group consisting of the proteins shown in Table 1 of the specification. Also described are proteins, nucleic acid fragments and their use for detection of whether a mammal has a high likelihood of having hypertension or a genetic predisposition for the same as well as test kits for this purpose.
Patent NZ-336234-A (NZ)
Title: 1,8-Annelated quinolinone derivatives such as pyrrolo[3,2,1-ij]quinolin-4-one, benzo[ij]quinolizin-5-one or oxazolo[5,4,3-ij]quinolin-4-one having farnesyl transferase inhibiting activity
Inventor: VENET MARC GASTON
IPC: C07D498/06
Filed: 1998-03-03
Abstract: The 1,8-annelated quinoline derivatives, pharmaceutically acceptable acid addition salts or stereochemically isomeric forms thereof have the formula I wherein: the dotted line is an optional double bond; X is O or S; A is -CH=CH-, -CH2-CH2-, -CH2-CH2-CH2-, -CH2-O-, -CH2-CH2-O-, -CH2-S-, -CH2-CH2-S-, -CH=N-, -N=N- or -CO-NH- wherein optionally one hydrogen may be replaced by alkyl or Ar1; R1 and R2 are independently H, OH, halo, CN, alkyl, trihalomethyl, trihalomethoxy, alkenyl, alkyloxy, hydroxyalkyloxy, alkyloxyalkyloxy, alkyloxycarbonyl, aminoalkyloxy, mono- or di- alkylaminoalkyloxy, Ar2, Ar2-alkyl, Ar2-oxy or Ar2-alkyloxy or on adjacent positions R2 and R1 together may be -O-CH2-O-, -O-CH2-CH2-O-, -O-CH=CH-, -O-CH2-CH2-, -O-CH2- CH2- CH2- or -CH=CH-CH=CH; R3 and R4 are independently H, halo, CN, alkyl, alkyloxy, Ar3-oxy, alkylthio, dialkylamino, trihalomethyl, trihalomethoxy or on adjacent positions R2 and R1 together may be -O-CH2-O-, -O-CH2-CH2-O- or -CH=CH-CH=CH; R5 is an optionally substituted 1- or 2- imidazolyl; R6 is H, OH, alkyl, CN, haloalkyl, hydroxyalkyl, cyanoalkyl, aminoalkyl, alkyloxyalkyl, alkylthioalkyl, aminocarbonylalkyl, alkyloxycarbonylalkyl, alkylcarbonylalkyl, alkyloxycarbonyl, mono- or di- alkylaminoalkyl, Ar5, Ar5-alkyloxyalkyl, OR7, SR7 or NR8R9; Ar1 to Ar3 and Ar5 are independently optionally substituted phenyl and the rest of the variables are as defined in the specification.  A pharmaceutical composition thereof is useful for inhibiting tumour growth and proliferative diseases.  A compound of formula VI wherein X, R1, R2 and A are as defined above provided that if X is oxygen and A is -CH2-CH2- then R1 and R2 are not both H is disclosed.  Also disclosed is a compound of formula II wherein X, Z, and R1 to R4 are as defined above.
Patent NZ-500059-A (NZ)
Title: Set of elements for forming furniture for visual display presentation, furniture and packaging assembly for said set
Inventor: MARCQ LAURENT
IPC: G09F15/00
Filed: 1999-02-24
Abstract: A set of elements for forming furniture (3) for visual display presentation (2) comprises at least in combination: lower (14) and upper (13) fixing means; support means (35) for example on the lower fixing means (14), designed to rest on the floor; a base (5) comprising at most one, even no means supporting (35) the set; and a lifting structure (41).
Patent NZ-502921-A (NZ)
Title: Coating composition for a plastic film that can be printed on.
Inventor: BOBO PASCALE
IPC: C08J7/04
Filed: 1998-07-10
Abstract: Described is an aqueous coating composition for a plastic film which comprises: (A) from 10 to 60% (by dry weight) of a water-dispersible copolymer comprising;    (A1) from 1 to 30% by weight, preferably from 3 to 10% by weight, of monomers selected from the group consisting of (meth)acrylamide, N-alkyl(meth)acrylamide and N-hydroxyalkyl(meth)acrylamide, and    (A2) from 70 to 99% by weight, preferably 90 to 97% by weight, of monomers selected from the group consisting of (meth)acrylic acid, alkyl (meth)acrylate, wherein the alkyl group contains straight or branched chains having from 1 to 8 carbon atoms, and (B) from 3 to 40% (by dry weight) preferably more than 5% of a crosslinker for the functional groups of the monomers of groups (A1), and (C) from 13 to 85% (by dry weight) of ink receptive particles. This composition imparts computer imprintable characteristics to a plastic film.
Patent NZ-503087-A (NZ)
Title: A secondary coupler (such as resorcinol) in conjunction with 5,6-dihydroxyindoline to produce coloured hair
Inventor: HOEFFKES HORST
IPC: A61Q5/10
Filed: 1998-07-22
Abstract: Oxidation colorants which contain at least one secondary intermediate and at least one derivative of 5,6-dihydroxyindoline corresponding to formula (I): in which-independently of one another-R1 is hydrogen, a C1-4alkyl group or a C1-4hydroxyalkyl group, R2 is hydrogen or a -COOH group which may even be present as a salt with a physiologically compatible cation, R3 is hydrogen or a C1-4alkyl group, R4 is hydrogen, a C1-4alkyl group or a group -CO-R6 where R6 is a C1-4alkyl group and R5 is one of the groups mentioned for R4, or a physiologically compatible salt of these compounds with an organic or inorganic acid in an aqueous carrier and which are free from oxidation dye precursors of the primary intermediate type enable hair to be coloured in particular in black tones with no tinges of red. In particular, completely or partly grey hair can be coloured in tones which come very close to the colour of the hair before greying.
Patent NZ-504784-A (NZ)
Title: Pluripotent embryonic stem cells and methods of obtaining them
Inventor: LORING JEANNE F
IPC: A01K67/027
Filed: 1998-11-25
Abstract: A method of obtaining embryonic stem cells from a target species whereby cells obtained from an embryo of a target species are co-cultured with non-target embryonic stem cells and then the target embryonic stem cells are isolated.
Patent NZ-506782-A (NZ)
Title: Mobile office briefcase allowing integration of computer, printer, scanner, and phone
Inventor: RYDER MARTIN DENNIS HENRY
IPC: G06F1/16
Filed: 2000-09-07
Abstract: A carrying case such as a briefcase for a mobile office, holding a number of interconnected electronic devices such as a laptop, a compute, a printer, which may be opened up at any place for immediate use of the devices is disclosed, wherein the carrying case comprises a rectangular rigid frame, shock absorbing foam and straps, the foundation and ancillary items being fastened to the frame, an enclosing cover having a zipper being attached to the frame and an optional wheeled caddie for supporting the frame using coupling blocks on each side of the frame. When the device is in use, the laptop extends forward from the frame in a low flat position, the printer that is held on the second tray is flipped backwards by 270 degrees over the top of the frame, so that the weight of the printer and the weight of the laptop tend to counterbalance each other which imparts stability to the carrying case during its use.
Patent NZ-507078-A (NZ)
Title: Method for transmission between two fax machines in a telecommunication system using two connections
Inventor: GUNGERSEN BENTE BJORNGARD
IPC: H04N1/00
Filed: 1999-04-09
Abstract: The method relates to a transmission between terminals in a telecommunication system, especially the transmission between two fax machines connected for fax transmission, and in order to solve the problem of long delays and enhance the utilisation of the protocols in question, it is suggested that the total connection between the two fax machines are divided in at least two separate connections.
Patent NZ-514524-A (NZ)
Title: Post foaming cleaning compositions
Inventor: POLLACK CHARLES A
IPC: C11D1/86
Filed: 2000-04-06
Abstract: A post foaming light duty liquid cleaning composition comprising by weight: (a) 8% to 29% of at least one sulfonate surfactant selected from the group consisting of sodium or magnesium salt of a linear C8-C18 alkyl benzene sulfonate and sodium or magnesium salt of a C8-C18 paraffin sulfonate and mixtures thereof; (b) 2% to 24% of at least one ethoxylated alkyl ether sulfate selected from the group consisting of sodium, ethoxylated C8-C18 alkyl ether sulfate ammonium ethoxylated C8-C18 alkyl ether sulfate and sodium ethoxylated C8-C18 alkyl ether sulfate and mixtures thereof; (c) 0% to 10% of a surfactant selected from the group consisting of betaine surfactants and amine oxide surfactants and mixtures thereof; (d) 1% to 16% of an alkyl polyglucoside; (e) 0 to 4% of a mono- or di-alkanol amide; (f) 0 to 20% of an ethoxylated nonionic surfactant; (g) 0 to 0.6% of a fragrance; (h) 7% to 14% of isopentane; and (i) 60% to 80% of water.
Patent NZ-516489-A (NZ)
Title: Laser joining toothbrush heads to handles
Inventor: RUSSELL BRUCE M
IPC: A46B5/00
Filed: 2000-07-10
Abstract: The present invention relates to a method of welding pre-formed toothbrush heads (14) and handles (18) using a about 0.7 to about 2.0 micrometers, or about 4.0 to about 6.0 micrometers, wavelength laser beam.
Patent NZ-520411-A (NZ)
Title: Self-normalizing flow sensor and method for the same
Inventor: ULRICH BONNE
IPC: G01F5/00
Filed: 2001-01-09
Abstract: An apparatus to normalize a flow rate of a fluid in a main flow channel is provided. The apparatus uses a moveable member, such as a flexible membrane disposed for reciprocating displacement, to produce a constant dither flow of the fluid that is independent of fluid composition. This dither flow generates a signal output from a normalizing flow sensor that both represents a characteristic property of the fluid and a flow rate calibration factor. The device disclosed may be sued in numerous industrial, process, and medical flow system applications for normalization of flow sensors and to derive other properties of a fluid.
Patent NZ-526781-A (NZ)
Title: System and method for managing patient care
Inventor: EGGERS PHILIP N
IPC: G06F19/00
Filed: 2002-02-25
Abstract: A patient care system comprising a patient care device having a plurality of configuration databases stored in a memory in the device. Each configuration database comprises a plurality of device operating parameters such as protocols, operating limits, rule sets and/or operating features that collectively define an operating environment, or personality, of the device. Selection of a specific configuration database is based at least in part upon patient-specific information obtained from any location in a distributed hospital network. Programming a patient care device to deliver a drug to a patient entails activating a configuration database and scanning a machine-readable drug label identifying a particular protocol stored in the activated database. The selected protocol includes default parameters for delivering the drug, and the label optionally includes instructions for deviating from the default protocol.
Patent NZ-529724-A (NZ)
Title: Cleaning system utilizing an organic cleaning solvent and a pressurized fluid solvent
Inventor: SCHULTE JAMES E
IPC: B08B3/12
Filed: 2002-04-18
Abstract: A cleaning system that utilizes an organic cleaning solvent and pressurized fluid solvent is disclosed. The system has no conventional evaporative hot air drying cycle. Instead, the system utilizes the solubility of the organic solvent in pressurized fluid solvent as well as the physical properties of pressurized fluid solvent. After an organic solvent cleaning cycle, the solvent is extracted from the textiles at high speed in a rotating drum (112, 122) in the same way conventional solvents are extracted from textiles in conventional evaporative hot air dry cleaning machines. Instead of proceeding to a conventional drying cycle, the extracted textiles are then immersed in pressurized fluid solvent to extract the residual organic solvent from the textiles. This is possible because the organic solvent is soluble in pressurized fluid solvent. After the textiles are immersed in pressurized fluid solvent, pressurized fluid solvent is pumped from the drum (112, 122). Finally, the drum is de-pressurized to atmospheric pressure to evaporate any remaining pressurized fluid solvent, yielding clean, solvent free textiles. The organic solvent is preferably selected from terpenes, halohydrocarbons, certain glycol ethers, polyols, ethers, esters of glycol ethers, esters of fatty acids and other long chain carboxylic acids, fatty alcohols and other long-chain alcohols, short-chain alcohols, polar aprotic solvents, siloxanes, hydrofluoroethers, dibasic esters, and aliphatic hydrocarbons solvents or similar solvents or mixtures of such solvents and the pressurized fluid solvent is preferably densified carbon dioxide.
Patent NZ-530074-A (NZ)
Title: Methods and compositions utilizing quinazolinones
Inventor: FINER JEFFREY T
IPC: G01N33/566
Filed: 2003-12-10
Abstract: Quinazolinone derivatives which are inhibitors of mitotic kinesin KSP and are useful in the treatment of cellular proliferative diseases, for example cancer, hyperlasias, restenosis, cardiac hypertrophy, immune disorders and inflammation is disclosed. A pharmaceutical composition comprising a compound chosen from the group consisting of formulae (I)-(IV) and a pharmaceutically acceptable carrier, diluent or excipient is also disclosed, where: R1 is chosen from hydrogen, alkyl, aryl, alkylaryl, heteroaryl, alkylheteroaryl, substituted alkyl, substituted aryl, substituted alkylaryl, substituted heteroaryl, and substituted alkylheteroaryl; R2 and R2' are independently chosen from hydrogen, alkyl, oxaalkyl, aryl, alkylaryl, heteroaryl, alkylheteroaryl, substituted alkyl, substituted aryl, substitutedalkylaryl, substituted heteroaryl, and substituted alkylheteroaryl; or R2 and R2' taken together form a 3-to 7-membered ring; R3 is chosen from hydrogen, alkyl, aryl, alkylaryl, heteroaryl, alkylheteroaryl, substituted alkyl, substituted aryl, substituted alkylaryl, substituted heteroaryl, substituted alkylheteroaryl, oxaalkyl, oxaalkylaryl, substituted oxaalkylaryl, R15O-and R15-NH; R3' is chosen from hydrogen, alkyl, aryl, alkylaryl, heteroaryl, alkylheteroaryl, substituted alkyl, substituted aryl, substituted alkylaryl, substituted heteroaryl, substituted alkylheteroaryl, and Rl5-NH-; R3" is chosen from alkyl, aryl, alkylaryl, heteroaryl, alkylheteroaryl, substituted alkyl, substituted aryl, substituted alkylaryl, substituted heteroaryl, and substituted alkylheteroaryl; R4 is -(CH)mOH or -(CH2)pR16; R5, R6, R7 and R8 are independently chosen from hydrogen, alkoxy, halogen, fluoroalkyl, nitro, dialkylamino, alkylsulfonyl, alkylsulfonamido, sulfonamidoalkyl, sulfonamidoaryl, alkylthio, carboxyalkyl, carboxamido, aminocarbonyl, aryl, and heteroaryl; R15 is chosen from alkyl, aryl, alkylaryl, heteroaryl, alkylheteroaryl, substituted alkyl, substituted aryl, substituted alkylaryl, substituted heteroaryl, and substituted alkylheteroaryl; m is 2 or 3; p is 1 to 3; and R16 is chosen from amino, propylamino and azetidinyl. (62) Divided Out of 518480
Patent NZ-536768-A (NZ)
Title: Process for the manufacture of quinoline carboxamide derivatives using an alkane or cycloalkane solvent
Inventor: JANSSON KARL
IPC: C07D491/04
Filed: 2003-05-14
Abstract: Disclosed herein is a process for the preparation of the compounds of general formula (I); by reacting a quinoline-3-carboxylic acid ester derivative of formula A with an aniline derivative of formula B in a solvent selected from straight or branched alkanes and cycloalkanes or mixtures thereof with a boiling point between 80 and 200 DEG C, wherein the variables shown in these formulae are as defined in the specification.
Patent NZ-538985-A (NZ)
Title: Bacteriophage composition useful in treating food products to prevent bacterial contamination by escherichia coli bacteria
Inventor: AVERBACK PAUL
IPC: A61K35/74
Filed: 2001-11-15
Abstract: A method for preventing the growth of E. coli microorganisms of a food product comprising contacting the food product with a microbial growth inhibiting effective amount of a bacteriophage composition comprising the bacteriophage isolate B3, wherein the application time of said bacteriophage composition is for at least of fraction of a second to prevent the growth of microorganisms on the food product.
Patent NZ-541005-A (NZ)
Title: Peristaltic pump head and tube holder
Inventor: GIBSON DAVID JOHN MICHAEL
IPC: F04B43/12
Filed: 2005-06-29
Abstract: A container for holding at least one fluid for dispensing by a peristaltic pump, the container comprising a plurality of discrete magnetic or magnetisable areas in predetermined positions on the container to identify the container, which magnetic or magnetisable areas (once magnetised) are configured for detection by a pump assembly having a plurality of sensors in predetermined positions corresponding to the positions of the magnetic or magnetisable areas.
Patent NZ-544163-A (NZ)
Title: Complement inhibitors
Inventor: NUNN MILES ANDREW
IPC: C07K14/435
Filed: 2004-06-02
Abstract: Provided is a complement inhibitor polypeptide derived from tick saliva that inhibits the classical complement pathway and the alternative complement pathway by inhibiting cleavage of C5 by classical and alternative C5 convertases, wherein said complement inhibitor has a specified sequence or at least 70% identity thereto. Further provided are active fragments of said proteins, antibodies binding the proteins, DNAs encoding the proteins and uses of these material to produce the proteins and to vaccinate non-human animals and to inhibit the complement pathways in non-human cells, tissues or organisms.
Patent NZ-545024-A (NZ)
Title: Flow diverter and exhaust blower for a vibrating screen separator assembly
Inventor: FOUT GARY
Filed: 2002-03-28
Abstract: A flow diverter and a vacuum blower for vibrating screen separator assembly. The flow diverter decelerates and increases the exposed surface of materials. The exhaust blower removes vapours from the materials.